Welcome to this is my:
this is my: is an independent private medical provider with over 10 years’ experience of offering health screening and ultrasound imaging to self-funding, private medical insurance and NHS clients. Our current centre locations are based in Leeds City, Manchester Central, Hull the Deep, London Mayfair, Halifax Beechwood and Liverpool Fairfield.
Our Health Screening & Ultrasound Scans are for you and all of your family. We offer well-man, well-woman and well-baby services including body ultrasound imaging, physiotherapy, 4D baby bond scans, private obstetric care & antenatal classes.
We believe in clinical excellence whilst making the latest technologies easily available to everyone. Each person is cared for as an individual, with honesty, equality and respect. We break down the barrier between patient and clinician with a personal service.
Under the direction of Mr Gerald Mason, Consultant in Feto-maternal Medicine at Leeds General Infirmary and Professor Howard Cuckle, Emeritus Professor, School of Medicine, University of Leeds, this is my: was established in 2003 with a healthcare vision;
“We felt passionate about creating a centre of excellence that would above all, provide exceptional screening services that were personal, truly caring and accessible to all.”
Prof. Howard Cuckle
Mr Gerald Mason
Announcements & promotions
Non Invasive Prenatal Testing
NIPT >99.5% accurate
Safe, Simple & Accurate
Risk Free Screening
Available from only
Call to book
0845 272 9999
What is NIPT or non-invasive prenatal testing?
A simple and safe chromosomal screening test. Along with an ultrasound scan, NIPT requires only a small sample of maternal venous blood taken from a pregnant woman from 10 weeks’ gestation.
This sample contains your unborn baby’s DNA known as ‘cell free DNA’ (“cfDNA”). NIPT analyses cfDNA to tell if your baby is affected by a chromosomal abnormality including Down’s, Edwards’ and Patau syndromes. The NIPT test can, if requested, identify the gender of your baby and screen for more unusual conditions and syndromes. NIPT is risk free to both mother and baby and has a far greater accuracy than currently offered standard screening tests.
There are only a few companies / laboratories in the world currently offering NIPT the common companies, origin and their NIPT tests are listed below:
- Ariosa: USA: Harmony™
- BGI Health: China: NIFTY™
- Natera : USA: Panorama™
- Sequenom: USA: MATERNIT21™ PLUS
- Illumina : USA: Verifi®
Each company processes and analyses the cfDNA in different ways, but all offer screening for the 3 most common trisomies, Down’s, Edwards’ and Patau syndromes, with an accuracy of over 99% plus fetal gender if requested. However, this is my has researched the market and can offer you the test which has lowest blood sample redraw rate, for the shortest turnaround from sample to result at the best price.
- Highly Accurate: Adopts next-generation sequencing technology, with a detection rate of over 99.5%.
- Non-invasive: Only a 10ml sample of maternal venous blood is required.
- Risk free: Carries no risk of miscarriage.
- Early-test: Performed from 10 weeks in pregnancy for early detection and better clinical decisions.
- Can be used in a twin pregnancy.
Once an ultrasound scan has confirmed a viable pregnancy, a simple blood sample is taken from the mothers arm.
Your NIPT sample is sent to a specialist laboratory where the fetal cfDNA is analysed.
NIPT is a screening test and thus should your screen return a high risk result it is advised that the result is confirmed via amniocentesis or chorionic villus biopsy.
NIPT is dependent on the amount of cfDNA circulating within the mother’s blood stream, sometimes there is not enough to give a valid result. In these cases another blood sample would be needed.
NIPT testing alone does not provide information on physical defects, mosaicism, partial trisomy, translocations or triploidy and thus it is essential that a detailed ultrasound scan is undertaken for full evaluation purposes.
To help clients identify their needs easily we have divided our service offering into 4 key areas; baby, fertility, body and dna genetics. Many of the services have overlapping areas and our advisors will be happy to discuss your requirements.
this is my: baby
provides medically supported private pregnancy ultrasound scans and consultations from 6 – 42 weeks including early reassurance scans, pregnancy dating scans, reassurance viability scans, gender scans, anomaly scans, well-being scans, fetal echo cardiogram scans for congenital heart defects (CHD) and 4D baby scans from our dedicated centres in Leeds, Manchester, Hull and London.
We also offer a specialist chromosomal screening service from 10 weeks of your pregnancy using the latest cutting edge screening technology; non-invasive prenatal testing (NIPT) via either NIFTY™ or Harmony™ . A simple blood sample taken from the expectant mothers arm carries no miscarriage risk to a healthy baby but screens for conditions such as Down’s syndrome, Edwards’ syndrome and Patau syndrome. The option to check for the sex of your offspring is also available as part of this screen.
We continue to offer traditional first trimester 12 weeks Nuchal Screening and Addmark® testing plus our second trimester Genmark™ screen so patients can choose the option which best suits their needs.
All our screening tests have optimum detection rates which exceed the NHS offering and in the first trimester we can also include pre-eclampsia screening.
this is my: fertility
this is my fertility offers a fertility monitoring service for couples going abroad for IVF treatment who require local UK support for endometrial scans and follicle tracking scans plus any supporting blood tests.
this is my: body
provides a wide range of general body diagnostic ultrasound imaging services including abdominal scans, renal scans, aortic screening, pelvic scans, testicular scans and dedicated musculoskeletal (MSK) imaging.
this is my: dna genetics
provides peace of mind screening for a whole range of inherited genetic conditions including Cystic Fibrosis, Spinal Muscular Atrophy and Fragile X Syndrome. We also have a specific Jewish carrier screening test, Alef8, which screens 8 common conditions which are prevalent to the Ashkenazi Jewish population including Tay Sachs, Blooms Syndrome and Anemia Fanconi.
this is my: continually strives for clinical excellence and employs a specialist team of consultants, sonographers, counsellors, midwives, physiotherapists, researchers and support staff so that it can deliver proven medical breakthroughs and advanced practices as quickly as possible for the benefit of all.
Affordable pricing, extended opening hours and availability of same day appointments makes it accessible to all.
Our expertise is your reassurance.